Postpartum Psychosis: What It Is, What Causes It, and Why Fast Recognition Matters

Postpartum psychosis is one of the most severe conditions in psychiatry, and also one of the most misunderstood. It gets confused with postpartum depression, with "baby blues," and with psychosis in general, three things it overlaps with but is not the same as. This piece defines each term clearly, walks through what the research actually shows about causes, symptoms, and treatment, and ends with a set of plain-language takeaways.

One correction worth making at the outset: postpartum psychosis is not a subtype of major depressive disorder. The research consistently identifies it as predominantly a bipolar-spectrum condition, not a depressive one. That distinction isn't a technicality. It changes what treatment looks like, and getting it wrong can lead to the wrong medication being used, since antidepressants can actually worsen the condition in some cases (Sharma et al., 2017). The section below on diagnosis explains why the evidence points this direction.

What psychosis actually means

Psychosis is defined as a loss of the capacity to distinguish what is real from what is not (De Marcilla Lappin et al., 2025; Almuqrin et al., 2023). The World Health Organization characterizes it specifically through hallucinations and delusions that impair a person's perception of reality and their ability to meet ordinary demands of daily life (Almuqrin et al., 2023). A hallucination is a perception that occurs without any external stimulus causing it, seeing, hearing, or sensing something that isn't there. A delusion is a fixed, false belief held with total conviction despite clear evidence against it (Fusar-Poli et al., 2022).

Losing contact with reality involves more than hallucinations and delusions on their own. It typically includes a breakdown in ordinary social understanding, a growing sense of confusion or strangeness about the world, and a reduced ability to trust normal social cues, so that people, places, and events start to feel loaded with meaning they don't actually carry, or simply incomprehensible (Fusar-Poli et al., 2022). Many people describe an early phase of just feeling different, socially out of step, and increasingly unable to connect with others, often well before more obvious symptoms appear (Fusar-Poli et al., 2022).

Psychosis is also not all-or-nothing. Research on the "psychosis continuum" shows that subclinical psychotic experiences, brief, milder versions of these symptoms, are actually fairly common in the general population, and roughly 80% of them are transitory, resolving without ever becoming a diagnosable disorder (Van Os & Reininghaus, 2016; Os et al., 2008). Only a minority progress to something clinically significant, and what determines that progression is less about the presence of any single unusual experience and more about how convinced, persistent, distressing, and impairing it becomes (DeRosse & Karlsgodt, 2015).

What postpartum psychosis is, specifically

Postpartum psychosis is a severe psychiatric emergency involving a rapid onset of psychotic and mood symptoms in the period immediately following childbirth. It affects an estimated 1 to 2 women per 1,000 deliveries, a rate that holds consistently across both high- and low-income countries (Friedman et al., 2023; Jairaj et al., 2023; Vanderkruik et al., 2017). Onset is typically fast: most episodes begin between day 3 and day 10 postpartum, and in the largest phenomenological study to date, the median time from delivery to symptom onset was 10 days (Cohen et al., 2024; Jairaj et al., 2023).

Early warning signs include insomnia, anxiety, irritability, and rapid mood fluctuation (Jairaj et al., 2023; Perry et al., 2021). As the condition develops, it can present with delusions, hallucinations, both manic and depressive features, disorganized behavior, and cognitive impairment that represents a dramatic, sudden shift from how the person was functioning before (Friedman et al., 2023; Jairaj et al., 2023). A distinctive feature compared to psychosis outside the postpartum period is a higher rate of extreme confusion and visual hallucinations specifically (Jairaj et al., 2023; Perry et al., 2021).

A study of 130 admitted women identified three separate symptom patterns: a depressive profile, present in 41% of cases and the most common; a manic profile, in 34%; and an atypical profile marked by disorientation and disturbed consciousness, in 25% (Kamperman et al., 2017). Across the group, the most common individual symptoms were irritability (73%), abnormal thought content (72%), and anxiety (71%). Suicidal ideation was present in 19% of cases, and infanticidal ideation, meaning thoughts of harming the infant, appeared in 8% (Kamperman et al., 2017). Delusions or hallucinations involving the infant do occur and can be concealed by the affected woman out of shame or lack of insight into what's happening to her (Jairaj et al., 2023; Friedman et al., 2023).

How this differs from postpartum depression and baby blues

These three conditions get conflated constantly, and the differences matter clinically. Baby blues affects an estimated 50 to 85% of new mothers, appears within days of delivery, and resolves on its own without treatment or functional impairment (Sit et al., 2006; Tsokkou et al., 2024). Postpartum depression affects roughly 10 to 20% of women, tends to develop somewhat later in the postpartum period, and is impairing but rarely a psychiatric emergency (Sit et al., 2006; Osborne, 2018). Postpartum psychosis is different in kind, not just severity: it affects 0.1 to 0.2% of deliveries, arrives fastest of the three, and constitutes a genuine psychiatric emergency requiring immediate evaluation (Jairaj et al., 2023; Osborne, 2018).

Why the evidence points to bipolar disorder, not major depression

The predominant clinical understanding is that postpartum psychosis represents a manifestation of bipolar disorder specifically triggered by the physiological changes of childbirth. Between 72% and 88% of affected women meet criteria for bipolar or schizoaffective disorder (Perry et al., 2021; Sit et al., 2006; Jairaj et al., 2023; Meltzer-Brody et al., 2018; Kamperman et al., 2017), and in the largest phenomenological cohort studied, 71.8% met criteria specifically for Bipolar I Disorder with psychotic features (Cohen et al., 2024). Among women who already carry a bipolar I diagnosis, as many as 16% will experience an episode meeting the definition of postpartum psychosis at some point (Sharma et al., 2022). For a meaningful number of women, postpartum psychosis is actually the first time bipolar disorder ever presents itself (Friedman et al., 2023; Vanderkruik et al., 2017).

This is why the choice between antidepressants and mood stabilizers matters so much clinically. Antidepressants carry a documented risk of inducing mania, triggering rapid mood cycling, and worsening psychosis in people with an underlying bipolar vulnerability, which is why they are generally avoided in this specific condition even though they're a mainstay of ordinary postpartum depression treatment (Sharma et al., 2017; Kimmel et al., 2022).

Risk of recurrence is substantial. After a first episode, roughly 20 to 50% of women experience isolated postpartum psychosis, meaning episodes only ever occur after childbirth, while the rest go on to develop mood episodes outside the perinatal period as well, typically within the bipolar spectrum (Bergink et al., 2016). A prior episode of postpartum psychosis is itself the single strongest predictor of it happening again, with roughly a 50% recurrence risk in future pregnancies (Friedman et al., 2023; Bergink et al., 2016; Mulligan et al., 2026). Other elevated-risk factors include first-time motherhood and any personal history of a mood disorder (Osborne, 2018; Fusar-Poli et al., 2025; Tsokkou et al., 2024). In one large U.S. database analysis covering 12.3 million deliveries, the clinical factors most strongly associated with readmission for postpartum psychosis were a prior episode of postpartum psychosis itself, followed by depression, bipolar spectrum disorder, and schizophrenia spectrum disorder (Albers et al., 2023).

Why this is treated as a psychiatric emergency

Postpartum psychosis carries a genuine risk of suicide or infanticide if it goes untreated, and maternal suicide is the leading cause of direct maternal death in the first year after childbirth (Jairaj et al., 2023; Sit et al., 2006; Bergink et al., 2016; Kapila et al., 2024). This is why the standard of care is acute inpatient psychiatric admission, not outpatient monitoring (Jairaj et al., 2023; Bergink et al., 2016; Osborne, 2018).

What treatment actually looks like

The most influential treatment evidence comes from a stepwise protocol tested in 64 women with a first episode of postpartum psychosis. The approach starts with a benzodiazepine for a few days, which alone produced remission in about 6% of cases. If symptoms persist, an antipsychotic is added, bringing total remission to roughly 25%. If that's still not enough, lithium is added, which brought the cumulative remission rate to 98.4%. Electroconvulsive therapy (ECT) was reserved as a fourth step for anyone who didn't respond within 12 weeks, though in this particular study no one needed it (Bergink et al., 2015; Jairaj et al., 2023; Osborne, 2018).

Lithium has the strongest evidence specifically for preventing relapse after the acute episode resolves, with roughly 80% of women maintaining sustained remission at 9 months, a meaningfully better outcome than antipsychotic treatment alone (Bergink et al., 2015; Jairaj et al., 2023). ECT remains an important option for severe or treatment-resistant presentations, including cases involving catatonia or active suicidal or homicidal ideation. In one Swedish population-based study of 185 postpartum women, 87% responded to ECT, a notably higher response rate than the 73.5% seen in non-postpartum patients receiving ECT for other conditions (Rundgren et al., 2018; Grover et al., 2024). ECT is generally considered compatible with breastfeeding, and its side effects tend to be transient (Kurimay et al., 2025; Grover et al., 2024).

Sleep protection deserves specific mention as a nonpharmacological piece of treatment. Insomnia is one of the earliest and most prominent features of the condition, and sleep loss itself appears to increase vulnerability to relapse, making protected sleep a genuine clinical priority rather than an afterthought (Osborne, 2018; Kurimay et al., 2025). Even with effective treatment, the risk of readmission within 6 months remains high, around 31% in one Danish national study, underscoring how important close follow-up care is after the initial crisis passes (Hauge et al., 2023).

Where mother and baby are treated together

Mother-baby psychiatric units, which admit the mother and infant jointly, are the recommended standard of inpatient care specifically because they support maternal recovery while also protecting the mother-infant bond (Howard et al., 2022; Trevillion et al., 2019). The evidence for maternal symptom improvement in these units is strong and consistent: one UK study of over 1,000 mothers found 78% had a good clinical outcome, and 80% showed improved parenting capacity by discharge (Yadawad et al., 2021). In a cohort specifically tracking postpartum psychosis, impaired mother-infant bonding dropped from nearly 18% at admission to under 6% at discharge, a rate comparable to the general population (Gilden et al., 2020; Friedman et al., 2023).

One honest limitation is worth stating clearly: despite these strong symptom and bonding outcomes, the largest comparative study to date found no significant difference in 12-month readmission rates between mother-baby units and standard psychiatric wards (Howard et al., 2022). Women consistently report preferring mother-baby units over general psychiatric units (Carr et al., 2025), and satisfaction with care was significantly higher in mother-baby unit settings (Howard et al., 2022), but the readmission data indicate these units are not yet proven to reduce relapse risk on their own, which is a real gap between what feels supportive and what's been measured to actually prevent recurrence.

How this differs from treating ordinary postpartum depression

For contrast, ordinary postpartum depression, without psychotic features, is treated very differently. The best-supported approach matches treatment intensity to severity: cognitive behavioral therapy (CBT) is the first-line treatment for mild-to-moderate cases, with strong evidence across multiple clinical guidelines (Radoš et al., 2025; Durrani et al., 2025), while antidepressant medication, usually an SSRI such as sertraline, is reserved for more severe presentations (Dennis et al., 2024; Vasiliu, 2022). Sertraline is specifically favored during breastfeeding due to its minimal passage into breastmilk (Dennis et al., 2024). Telehealth and interpersonal therapy formats have also shown real effectiveness and help address access barriers like transportation, childcare, and specialist availability (Durrani et al., 2025; Dennis et al., 2020; Pan et al., 2025).

The key clinical distinction is this: SSRIs are appropriate first-line medication for ordinary postpartum depression, but they are generally avoided in postpartum psychosis specifically because of the risk of inducing mania in someone with an underlying bipolar vulnerability (Sharma et al., 2017). Getting the diagnosis right at the outset is what determines which of these two very different treatment paths a woman ends up on.

Key takeaways

• Psychosis means a loss of the ability to reliably distinguish what's real from what isn't, most often involving hallucinations, delusions, and disorganized thinking.

• Postpartum psychosis is rare, affecting roughly 1 to 2 per 1,000 births, but it is a genuine psychiatric emergency, not an extreme version of ordinary postpartum mood changes.

• It typically begins within the first 3 to 10 days after delivery and can escalate quickly, which is why fast recognition and evaluation matter.

• It is not a subtype of major depressive disorder. The strongest evidence links it to bipolar spectrum disorder, and for many women it is the first time bipolar illness has ever appeared.

• Because of that bipolar link, antidepressants can worsen the condition in some cases, which is why diagnosis needs to be accurate before treatment begins.

• A prior episode is the single strongest predictor of it happening again, with roughly a 50% recurrence risk in future pregnancies.

• The most effective treatment protocol found nearly universal remission using a stepwise approach: benzodiazepine, then antipsychotic, then lithium, with ECT available for anyone who doesn't respond.

• Lithium has the best evidence for preventing relapse after the acute crisis resolves.

• Sleep protection is a genuine clinical priority, since insomnia is both an early symptom and a documented trigger for relapse.

• Mother-baby psychiatric units improve maternal symptoms and mother-infant bonding substantially, though they haven't yet been shown to reduce readmission risk compared to standard psychiatric care.

• Suicidal and infanticidal thoughts can occur as part of this condition and are treated as medical symptoms of an underlying illness requiring urgent psychiatric care, not as a reflection of a mother's character or intentions.

This is a research synthesis intended for general education and is not a substitute for individualized medical advice. Anyone experiencing symptoms consistent with postpartum psychosis, or supporting someone who might be, needs immediate evaluation by a licensed clinician or emergency care. Given that this topic touches on suicide and infanticide risk as clinical features of a treatable illness, it's worth noting that if this is a personal concern rather than a general interest one, reaching out for support, whether to a healthcare provider, a crisis line, or someone trusted, is a reasonable and important next step.

References

Albers, S. M., Wen, T., Monk, C., Logue, T. C., D'Alton, M., Booker, W. A., & Friedman, A. (2023). Postpartum psychosis during delivery hospitalizations and postpartum readmissions, 2016-2019. American Journal of Obstetrics & Gynecology MFM, 100905. https://doi.org/10.1016/j.ajogmf.2023.100905

Almuqrin, A., Georgiades, A., Mouhitzadeh, K., Rubinic, P., Mechelli, A., & Tognin, S. (2023). The association between psychosocial stress, interpersonal sensitivity, social withdrawal and psychosis relapse: A systematic review. Schizophrenia, 9. https://doi.org/10.1038/s41537-023-00349-w

Bergink, V., Burgerhout, K., Koorengevel, K., Kamperman, A., Hoogendijk, W., Berg, M. L.-V. D. P., & Kushner, S. (2015). Treatment of psychosis and mania in the postpartum period. American Journal of Psychiatry, 172(2), 115-123. https://doi.org/10.1176/appi.ajp.2014.13121652

Bergink, V., Rasgon, N., & Wisner, K. (2016). Postpartum psychosis: Madness, mania, and melancholia in motherhood. American Journal of Psychiatry, 173(12), 1179-1188. https://doi.org/10.1176/appi.ajp.2016.16040454

Carr, V., Thomson, G., Moran, V., & Strachan, G. (2025). Women's experiences of care and support following postpartum psychosis: A meta-ethnography. Journal of Advanced Nursing, 82, 4714-4732. https://doi.org/10.1111/jan.70195

Cohen, L. S., Arakelian, M., Church, T. R., Dunk, M. M., Gaw, M. L., Yoon, H. E., Kobylski, L. A., Vanderkruik, R. C., & Freeman, M. P. (2024). The phenomenology of postpartum psychosis: Preliminary findings from the Massachusetts General Hospital Postpartum Psychosis Project. Molecular Psychiatry, 30, 2537-2544. https://doi.org/10.1038/s41380-024-02856-3

De Marcilla Lappin, I. G., Mana, L., Alemán-Gómez, Y., Alameda, L., Solida, A., Jenni, R., Baumann, P., Klauser, P., Conus, P., Kringelbach, M. L., Hagmann, P., Deco, G., & Perl, S. Y. (2025). Perturbations of whole-brain model reveal critical areas related to relapse of early psychosis. Network Neuroscience, 10, 62-79. https://doi.org/10.1162/netn.a.502

Dennis, C.-L., Singla, D., Brown, H. K., Savel, K., Clark, C. T., Grigoriadis, S., & Vigod, S. (2024). Postpartum depression: A clinical review of impact and current treatment solutions. Drugs, 84, 645-659. https://doi.org/10.1007/s40265-024-02038-z

Dennis, C., Grigoriadis, S., Zupancic, J., Kiss, A., & Ravitz, P. (2020). Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: Nationwide randomised controlled trial. British Journal of Psychiatry, 216, 189-196. https://doi.org/10.1192/bjp.2019.275

DeRosse, P., & Karlsgodt, K. H. (2015). Examining the psychosis continuum. Current Behavioral Neuroscience Reports, 2, 80-89. https://doi.org/10.1007/s40473-015-0040-7

Durrani, A., Fonseka, N., Sethi, M. R., Mughal, H., Khan, Z., Kingstone, T., Bajpai, R., & Farooq, S. (2025). Management of postnatal depression: A systematic review of clinical practice guidelines. Cambridge Prisms: Global Mental Health, 12. https://doi.org/10.1017/gmh.2025.10075

Friedman, S., Reed, E. R., & Ross, N. E. (2023). Postpartum psychosis. Current Psychiatry Reports, 25, 65-72. https://doi.org/10.1007/s11920-022-01406-4

Fusar-Poli, P., Estradé, A., Mathi, K., Mabia, C., Yanayirah, N., Floris, V., Figazzolo, E., Esposito, C. M., Mancini, M., Rosfort, R., Catalán, A., Baldwin, H., Patel, R., Stanghellini, G., Ratcliffe, M., & Maj, M. (2025). The lived experience of postpartum depression and psychosis in women: A bottom-up review co-written by experts by experience and academics. World Psychiatry, 24. https://doi.org/10.1002/wps.21264

Fusar-Poli, P., Estradé, A., Stanghellini, G., Venables, J., Onwumere, J., Messas, G., Gilardi, L., Nelson, B., Patel, V., Bonoldi, I., Aragona, M., Cabrera, A., Rico, J., Hoque, A., Otaiku, J., Hunter, N., Tamelini, M., Maschião, L. F., Puchivailo, M., & Maj, M. (2022). The lived experience of psychosis: A bottom-up review co-written by experts by experience and academics. World Psychiatry, 21. https://doi.org/10.1002/wps.20959

Gilden, J., Molenaar, N. M., Smit, A. K., Hoogendijk, W., Rommel, A.-S., Kamperman, A., & Bergink, V. (2020). Mother-to-infant bonding in women with postpartum psychosis and severe postpartum depression: A clinical cohort study. Journal of Clinical Medicine, 9. https://doi.org/10.3390/jcm9072291

Grover, S., Sharma, P., & Chakrabarti, S. (2024). Use of electroconvulsive therapy during postpartum: A retrospective chart review. Indian Journal of Psychiatry, 66, 572-575. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_165_24

Hauge, C., Rohde, C., & Østergaard, S. (2023). Treatment of postpartum psychotic- or mood disorder requiring admission: A nationwide study from Denmark. Acta Psychiatrica Scandinavica, 150, 395-403. https://doi.org/10.1111/acps.13585

Howard, L., Trevillion, K., Potts, L., Heslin, M., Pickles, A., Byford, S., Carson, L., Dolman, C., Jennings, S., Johnson, S., Jones, I., McDonald, R., Pawlby, S., Powell, C., Seneviratne, G., Shallcross, R., Stanley, N., Wieck, A., & Abel, K. M. (2022). Effectiveness and cost-effectiveness of psychiatric mother and baby units: Quasi-experimental study. British Journal of Psychiatry, 221, 628-636. https://doi.org/10.1192/bjp.2022.48

Jairaj, C., Seneviratne, G., Bergink, V., Sommer, I., & Dazzan, P. (2023). Postpartum psychosis: A proposed treatment algorithm. Journal of Psychopharmacology, 37, 960-970. https://doi.org/10.1177/02698811231181573

Kamperman, A., Veldman-Hoek, M. J., Wesseloo, R., Blackmore, R. E., & Bergink, V. (2017). Phenotypical characteristics of postpartum psychosis: A clinical cohort study. Bipolar Disorders, 19, 450-457. https://doi.org/10.1111/bdi.12523

Kimmel, M., Thippeswamy, H., Kamperman, A., Madhuri, H., Putnam, K., Schiller, C., Weinel, K., Rackers, H., Gilden, J., Bergink, V., Meltzer-Brody, S., & Chandra, P. (2022). Cross-continental collaboration for understanding postpartum major depression with psychotic features. Frontiers in Global Women's Health, 3. https://doi.org/10.3389/fgwh.2022.996501

Kurimay, T., Pelikán, A., & Tory, V. (2025). State-of-the-art treatment of postpartum bipolar disorder. Current Opinion in Psychiatry, 39, 32-41. https://doi.org/10.1097/yco.0000000000001049

Meltzer-Brody, S., Howard, L., Bergink, V., Vigod, S., Jones, I., Munk-Olsen, T., Honikman, S., & Milgrom, J. (2018). Postpartum psychiatric disorders. Nature Reviews Disease Primers, 4. https://doi.org/10.1038/nrdp.2018.22

Mulligan, Z., Smyth, S., & Babatola, O. (2026). Postpartum psychosis presenting with catatonia: A case study. BJPsych Open, 12, S377-S378. https://doi.org/10.1192/bjo.2026.11868

Os, J., Linscott, R., Myin-Germeys, I., Delespaul, P., & Krabbendam, L. (2008). A systematic review and meta-analysis of the psychosis continuum: Evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine, 39, 179-195. https://doi.org/10.1017/s0033291708003814

Osborne, L. (2018). Recognizing and managing postpartum psychosis: A clinical guide for obstetric providers. Obstetrics and Gynecology Clinics of North America, 45, 455-468. https://doi.org/10.1016/j.ogc.2018.04.005

Pan, J., Luo, W., Zhang, H., Wang, Y., Lu, H., Wang, C., Li, C., Fu, L., Hu, Y., Li, Y., & Shen, M. (2025). The effects of online cognitive behavioral therapy on postpartum depression: A systematic review and meta-analysis. Healthcare, 13. https://doi.org/10.3390/healthcare13070696

Perry, A., Gordon-Smith, K., Jones, L., & Jones, I. (2021). Phenomenology, epidemiology and aetiology of postpartum psychosis: A review. Brain Sciences, 11. https://doi.org/10.3390/brainsci11010047

Radoš, S. N., Ganho-Ávila, A., Rodríguez-Muñoz, M. F., Bina, R., Kittel-Schneider, S., Berg, M. L.-V. D. P., Lega, I., Lupattelli, A., Sheaf, G., Skalkidou, A., Uka, A., Uusitalo, S., Abeele, L. B.-V., & Moura-Ramos, M. (2025). Evidence-based clinical practice guidelines for prevention, screening and treatment of peripartum depression. British Journal of Psychiatry, 227, 798-809. https://doi.org/10.1192/bjp.2025.43

Rundgren, S., Brus, O., Båve, U., Landén, M., Lundberg, J., Nordanskog, P., & Nordenskjöld, A. (2018). Improvement of postpartum depression and psychosis after electroconvulsive therapy: A population-based study with a matched comparison group. Journal of Affective Disorders, 235, 258-264. https://doi.org/10.1016/j.jad.2018.04.043

Scott, I., Aarts, E., Wannan, C., Gao, C. X., Clark, S. R., Hartmann, S., Nguyen, J., Cavve, B. S., Hartmann, J., Dwyer, D., Van Der Tuin, S., Raposo-Almeida, E., Lin, A., Amminger, G., Thompson, A., Wood, S. J., Yung, A. R., Van Den Berg, D. V. D., McGorry, P., & Nelson, B. (2025). Characterising symptomatic substates in individuals on the psychosis continuum: A hidden Markov modelling approach. Psychological Medicine, 55. https://doi.org/10.1017/s003329172500056x

Sharma, V., Doobay, M., & Baczynski, C. (2017). Bipolar postpartum depression: An update and recommendations. Journal of Affective Disorders, 219, 105-111. https://doi.org/10.1016/j.jad.2017.05.014

Sharma, V., Mazmanian, D., Palagini, L., & Bramante, A. (2022). Postpartum psychosis: Revisiting the phenomenology, nosology, and treatment. Journal of Affective Disorders Reports. https://doi.org/10.1016/j.jadr.2022.100378

Sit, D., Rothschild, A., & Wisner, K. (2006). A review of postpartum psychosis. Journal of Women's Health, 15, 352-368. https://doi.org/10.1089/jwh.2006.15.352

Tsokkou, S., Kavvadas, D., Georgaki, M.-N., Papadopoulou, K., Papamitsou, T., & Karachrysafi, S. (2024). Genetic and epigenetic factors associated with postpartum psychosis: A 5-year systematic review. Journal of Clinical Medicine, 13. https://doi.org/10.3390/jcm13040964

Trevillion, K., Shallcross, R., Ryan, E., Heslin, M., Pickles, A., Byford, S., Jones, I., Johnson, S., Pawlby, S., Stanley, N., Rose, D., Seneviratne, G., Wieck, A., Jennings, S., Potts, L., Abel, K., & Howard, L. (2019). Protocol for a quasi-experimental study of the effectiveness and cost-effectiveness of mother and baby units compared with general psychiatric inpatient wards and crisis resolution team services (the ESMI study). BMJ Open, 9. https://doi.org/10.1136/bmjopen-2018-025906

Vanderkruik, R., Barreix, M., Chou, D., Allen, T., Say, L., Cohen, L., Cecatti, J., Cottler, S., Fawole, O., Filippi, V., Firoz, T., Ghérissi, A., Gichuhi, G. N., Gyte, G., Hindin, M., Jayathilaka, A., Koblinsky, M., Kone, Y., Kostanjsek, N., & Von Dadelszen, P. (2017). The global prevalence of postpartum psychosis: A systematic review. BMC Psychiatry, 17. https://doi.org/10.1186/s12888-017-1427-7

Van Os, J., & Reininghaus, U. (2016). Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry, 15. https://doi.org/10.1002/wps.20310

Vasiliu, O. (2022). Pharmacological treatment strategies for postpartum depression. European Psychiatry, 65, S562. https://doi.org/10.1192/j.eurpsy.2022.1438

Yadawad, V., Ganjekar, S., Thippeswamy, H., Chandra, P., & Desai, G. (2021). Short-term outcome of mothers with severe mental illness admitted to a mother baby unit. Indian Journal of Psychiatry, 63, 245-249. https://doi.org/10.4103/psychiatry.indianjpsychiatry_1005_20